Roche expands Global Access Program to include the first fully automated CE marked nucleic acid HIV-1/HIV-2 qualitative diagnostic test.
Sunday, 10 September 2017
Differentiates between HIV-1 and HIV-2 infections to confidently treat patients based on HIV subtype infection – Significant reduction in time to detection is critical in curbing further disease transmission – Access to testing in rural areas through validated dried blood spot (DBS) collection card PLEASANTON, California, July 25, 2017 /PRNewswire/ — Roche
- Published in Health & life sciences
No Comments
Roche launches the AVENIO Millisect System for precise and efficient dissection of tissue biopsies
Tuesday, 22 August 2017
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the commercial availability of the AVENIO Millisect System, a tissue dissection instrument that utilizes an automated digitally assisted process to reliably and efficiently isolate clinically relevant cells from formalin-fixed paraffin-embedded (FFPE) tissue slides. The AVENIO Millisect System addresses challenges inherent in today’s tissue dissection practice in the
- Published in Health & life sciences